Product image of Hemlibra-60mg IND (Emicizumab) 60mg/0.4ml Vials supplied by GNH India

Hemlibra-60mg IND

Active Ingredient:
Emicizumab
Form:
Vials
Brand:
Hemlibra-60mg
Origin:
India

Hemlibra-60mg IND (Emicizumab Vials) 60mg/0.4ml

Hemlibra 60mg (Emicizumab) is a prescription medication formulated as 60mg/0.4ml vials for subcutaneous use. It is indicated for hemophilia A to reduce bleeding episodes and manage inhibitor-related complications. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance.

Strength

60mg/0.4ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Emicizumab, the active ingredient in Hemlibra 60mg, is used to prevent or reduce the frequency of bleeding episodes in people with hemophilia A. It is particularly beneficial for individuals who have developed inhibitors to factor VIII therapy. The medication works by bridging activated factor IX and factor X, restoring the natural blood clotting process. Hemlibra is not used to treat other types of bleeding disorders.

Side Effects

  • Hemlibra 60mg helps the blood clot more effectively, which can reduce the need for additional treatments like factor VIII infusions. Users may experience fewer spontaneous bleeding episodes and improved overall management of their condition. Regular use as directed can contribute to better quality of life by minimizing interruptions from bleeding events. Individual responses may vary.

Precautions & Warnings

  • Store Hemlibra 60mg vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials. Always check the solution for particles or discoloration before use; discard if either is present. Keep the medication out of reach of children and pets. Follow the handling and disposal instructions provided by your healthcare provider or pharmacist.

Avoid Interactions

  • Hemlibra may interact with other medications, particularly those affecting blood clotting or coagulation pathways. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Avoid starting or stopping any medications without consulting your doctor, as this could impact Hemlibra’s effectiveness or safety. Alcohol and certain dietary supplements may also interact; discuss these with your provider.

References

Frequently Asked Questions

Hemlibra 60mg is used to prevent or reduce bleeding episodes in people with hemophilia A, especially those who have developed inhibitors to factor VIII therapy.

Store Hemlibra 60mg vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials.

No, Hemlibra 60mg is specifically indicated for hemophilia A and is not used to treat other types of bleeding disorders.

Contact your healthcare provider for guidance if you miss a dose. Do not take a double dose to make up for a missed one.

Common side effects may include injection site reactions, headache, or joint pain. Report any persistent or severe side effects to your healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Emicizumab

Hemlibra 30mg

Hemlibra 30mg

30mg/1ml Vials
Hemlibra-30mg

Hemlibra-30mg

30mg/ml Vials
Hemlibra 30 mg

Hemlibra 30 mg

30 MG SOLUTION
Hemlibra 60 mg

Hemlibra 60 mg

60 MG SOLUTION

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT